On the supposed influence of milk homogenization on the risk of CVD, diabetes and allergy

British Journal of Nutrition

Volumn 97, Issue 4, 2007, Pages 598-610

  Michalski, Marie Caroline ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Allergy; Cardiovascular disease; Diabetes; Milk; Process

Indexed keywords

CASEIN; FAT DROPLET; HYDROGEN PEROXIDE; MILK PROTEIN; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHEESEMAKING; DAIRY PRODUCT; DIABETES MELLITUS; DIABETOGENESIS; DISEASE PREDISPOSITION; FOOD COMPOSITION; FOOD INTAKE; FOOD PROCESSING; HEART INFARCTION; HEATING; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LACTOSE INTOLERANCE; MILK ALLERGY; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PARTICLE SIZE; PASTEURIZATION; POSTPRANDIAL STATE; PRIMARY PREVENTION; REVIEW; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; CATTLE; DIABETES MELLITUS, TYPE 1; DIGESTION; FOOD HANDLING; HUMANS; MILK; MILK HYPERSENSITIVITY;

EID: 33947547506     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507657900     Document Type: Review

References (130)

1. Aimutis W (2004) Bioactive properties of milk proteins with particular focus on anticariogenesis. J Nutr 134, 989S-995S.
2. Allison A & Clarke A (2006) Further research for consideration in 'the A2 milk case'. Eur J Clin Nutr 60, 921-924.
3. Armand M, Pasquier B, André M, Borel P, Senft M, Peyrot J, Salducci J, Portugal H, Jaussan V & Lairon D (1999) Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract. Am J Clin Nutr 70, 1096-1106.
4. Barba G, Troiano E, Russo P, Venezia A & Siani A (2005) Inverse association between body mass and frequency of milk consumption in children. Br J Nutr 93, 15-19.
5. Bell S, Grochoski G & Clarke A (2006) Health implications of milk containing beta-casein with the A2 genetic variant. Crit Rev Food Sci Nutr 46, 93-100.
6. Berner L (1993a) Roundtable discussion on milkfat, dairy foods, and coronary heart disease risk. J Nutr 110, 1175-1184.
7. Berner L (1993b) Defining the role of milkfat in balanced diets. Adv Food Nutr Res 37, 131-257.
8. Berry C & Hare J (2004) Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications. J Physiol 555, 589-606.
9. Besler M, Paschke A & Paschke A (2001) Stability of food allergens and allergenicity of processed foods. J Chromatogr 756B, 207-228.
10. Birgisdottir B, Hill J, Thorsson A & Thorsdottir I (2006) Lower consumption of cow milk protein A1 beta-casein at 2 years of age, rather than consumption among 11- to 14-year-old adolescents, may explain the lower incidence of type 1 diabetes in Iceland than Scandinavia. Ann Nutr Metab 50, 177-183.
11. Bouhallab S & Bougle D (2004) Biopeptides of milk: caseinophosphopeptides and mineral bioavailability. Reprod Nutr Dev 44, 493-498.
12. Briley M & Eisenthal R (1975) Association of xanthine oxidase with the bovine milk-fat-globule-membrane. Nature of the enzymemembrane association. Biochem J 147, 417-423.
13. Buchheim W (1984) Zum Einfluss unterschiedlicher technologischer Behandlung von Milch auf die Verdauugsvorgange im Magen. IV. Elektronenmikroskopische Charakterisierung des Koagulums und lipolytischer Vorgange im Magen. (Influence of different technological treatments of milk on digestion in the stomach. IV. Electron microscopic characterization of the coagulum and of lipolytic processes in the stomach). Milchwissenschaft 39, 271-275.
14. Chin-Dusting J, Shennan J, Jones E, Williams C, Kingwell B & Dart A (2006) Effect of dietary supplementation with b-casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease. Br J Nutr 95, 136-144.
15. Clemente G, Mancini M, Nazzaro F, Lasorella G, Rivieccio A, Palumbo A, Rivellese A, Ferrara L & Giacco R (2003) Effect of different dairy products on postprandial lipemia. Nutr Metab Cardiovasc Dis 13, 377-383.
16. Dahl-Jorgensen K, Joner G & Hanssen K (1991) Relationship between cow's milk consumption and incidence of IDDM in childhood. Diabetes Care 14, 1081-1083.
17. Dahlqvist A (1983) Lactose digestion and lactase deficiencies. In Milk Intolerances and Rejection, pp. 11-16 [J Delmont, editor]. Nice: Kargel, S.
18. Danthine S, Blecker C, Paquot M, Innocente N & Deroanne C (1999) Evolution des connaissances sur la membrane du globule gras du lait: synthèse bibliographique. Lait 80, 209-222.
19. Darling D & Butcher D (1978) Milk-fat globule membrane in homogenized cream. J Dairy Res 45, 197-208.
20. Demott B & Praepanitchai O (1978) Influence of storage, heat, and homogenization upon xanthine oxidase activity of milk. J Dairy Sci 61, 164-167.
21. Elliott R, Harris D, Hill J, Bibby N & Wasmuth H (1999) Type I (insulin-dependent) diabetes mellitus and cow milk: Casein variant consumption. Diabetologia 42, 292-296.
22. Elwood P, Pickering J, Hughes J, Fehily A & Ness A (2004) Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr 58, 718-724.
23. Evangelisti F, Calcagno C, Nardi S & Zunin P (1904) Deterioration of protein fraction by Maillard reaction in dietetic milks. J Dairy Res 66, 237-243.
24. Fava D, Leslie R & Pozzilli P (1994) Relationship between dairy product consumption and incidence of IDDM in childhood in Italy. Diabetes Care 17, 1488-1490.
25. Favé G, Coste T & Armand M (2004) Physicochemical properties of lipids: New strategies to manage fatty acid bioavailability. Cell Mol Biol 50, 815-831.
26. Feng C & Collins A (1999) Pasteurisation and homogenisation of milk enhances the immunogenicity of milk plasma proteins in a rat model. Food Agric Immunol 11, 251-258.
27. German J & Dillard C (2006) Composition, structure and absorption of milk lipids: A source of energy, fat-soluble nutrients and bioactive molecules. Crit Rev Food Sci Nutr 46, 57-92.
28. Gobbetti M, Stepaniak L, De Angelis M, Corsetti A & Di Cagno R (2002) Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing. Crit Rev Food Sci Nutr 42, 223-239.
29. Goudédranche H, Maubois J & Fauquant J (1998) Produits, en particulier laitiers, comprenant des fractions sélectionnées de globules gras, obtention et applications. French Patent FR/2/776/208/A1, 24 p, International Patent PCT/FR 99/00632.
30. Guo M, Hendricks G & Kindstedt P (1998) Component distribution and interactions in powdered infant formula. Int Dairy J 8, 333-339.
31. Gurr M (1995) Nutritional significance of lipids. In Advanced Dairy Chemistry. 2. Lipids, pp. 349-402 [P Fox, editor]. London: Chapman & Hall.
32. Hajjar R & Leopold J (2006) Xanthine oxidase inhibition and heart failure: Novel therapeutic strategy for ventricular dysfunction? Circ Res 98, 169-171.
33. Hansen L, Host A & Osterballe O (1987) Allergiske reaktioner pa uhomogeniseret maelk og ramaelk. (Allergic reactions to unhomogenized milk and raw milk). Ugeskr Laeger 149, 909-911.
34. Hill J & Boland M (2001) The milk protein variants - relationships with health and disease. Aust J Dairy Technol 56, 117-122.
35. Ho C & Clifford A (1977) Bovine milk xanthine oxidase, blood lipids and coronary plaques in rabbits. J Nutr 107, 758-766.
36. Horne D (2006) Casein micelle structure: Models and muddles. Curr Opin Colloid Interface Sci 11, 148-153.
37. Host A (2002) Frequency of cow's milk allergy in childhood. Ann Allergy Asthma Immunol 89, S33-S37.
38. Host A, Halken S, Jacobsen H, Christensen A, Herskind A & Plesner K (2002) Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood. Pediatr Allergy Immunol 13, S23-S28.
39. Host A & Samuelsson E-G (1988) Allergic reactions to raw, pasteurized, and homogenized/pasteurized cow milk: A comparison. A double-blind placebo-controlled study in milk allergic children. Allergy 43, 113-118.
40. Hoyt G, Hickey M & Cordain L (2005) Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr 93, 175-177.
41. Hui Y (1993) Engineering: Plant design, processing, and packaging. In Dairy Science and Technology Handbook: Applications Science, Technology and Engineering, [Y Hui, editor]. New York: John Wiley & Sons.
42. Ikeda S, Fögeding E & Hardin C (2000) Phospholipid/fatty acid-induced secondary structural changes in beta-lactoglobulin during heat-induced gelation. J Agric Food Chem 48, 605-610.
43. Jackson R & Brunner J (1960) Characteristics of protein fractions isolated from fat/plasma interface of homogenized milk. J Dairy Sci 43, 912-919.
44. Jensen R (1995) Handbook of Milk Composition. San Diego: Academic Press.
45. Jensen R (2002) The composition of bovine milk lipids: January 1995 to December 2000. J Dairy Sci 85, 295-350.
46. Jinsmaa Y & Yoshikawa M (1999) Enzymatic release of neo-casomorphin and beta-casomorphin from bovine beta-casein. Peptides 20, 957-962.
47. Karjalainen J, Martin J, Knip M, Robinson B, Savilahti E, Akerblom H & Dosch H (1992) A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 327, 302-307.
48. Kaufmann W (1984) Zum Einfluss unterschiedlicher technologischer Behandlung von Milch auf die Verdauungsvorgange im Magen. VI. Messungen von Aminosaure- und Harnstoffgehalten im Blut; Schlussfolgerungen zur ernahrungsphysiologischen Bewertung. (Influence of different technological treatments of milk on digestion in the stomach. VI. Estimation of amino acids and urea in blood; conclusions regarding nutritional evaluation). Milchwissenschaft 39, 281-284.
49. Keenan T, Moon T & Dylewski D (1983) Lipid globules retain globule membrane material after homogenization. J Dairy Sci 66, 196-203.
50. Korhonen H & Korpela R (1994) The effects of dairy processes on the components and nutritional value of milk. Scand J Nutr 38, 166-172.
51. Korpela R, Paajanen L & Tuure T (2005) Homogenization of milk has no effect on the gastrointestinal symptoms of lactose intolerant subjects. Milchwissenschaft 60, 3-6.
52. Kostraba J, Cruiskshanks K, Lawler-Heavner J, Jobim L, Rewers M, Ga E, Chase H, Klingensmith G & Hamman R (1993) Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes 42, 288-295.
53. Kvistgaard A, Pallesen L, Arias C, López S, Petersen T, Heegaard C & Rasmussen J (2004) Inhibitory effects of human and bovine milk constituents on rotavirus infections. J Dairy Sci 87, 4088-4096.
54. 15N] milk proteins measured in rats. J Agric Food Chem 54, 1508-1517.
55. Langley-Danysz P (1993) Hautes pressions, un atout pour le secteur laitier.) The advantages of the use of high pressure treatment in the dairy sector). Revue Laitière Française 531, 26-29.
56. Lawlor D, Ebrahim S, Timpson N & Davey Smith G (2005) Avoiding milk is associated with à reduced risk of insulin resistance and the metabolic syndrom: Findings from the British Women's Heart and Health Study. Diabet Med 22, 808-811.
57. Lee K, Lee H, Cho H & Kim Y (2005) Role of the conjugated linoleic acid in the prevention of cancer. Crit Rev Food Sci Nutr 45, 135-144.
58. Lindquist A (1998) A method for the production of sterile skimmed milk. Patent PCT WO No. 57549.
59. Lopez C (2005) Focus on the supramolecular structure of milk fat in dairy products. Reprod Nutr Develop 45, 497-511.
60. Maijala K (2000) Cow milk and human development and well-being. Livestock Prod Sci 65, 1-18.
61. Mangino M & Brunner J (1976) Homogenized milk: Is it really the culprit in dietary-induced atherosclerosis? J Dairy Sci 59, 1511-1512.
62. Mann J (2002) Diet and risk of coronary heart disease and type 2 diabetes. Lancet 360, 783-789.
63. Mather I (2000) A review and proposed nomenclature for the major proteins of the milk fat globule membrane. J Dairy Sci 83, 203-247.
64. 1, ischaemic heart disease mortality, and other illnesses. Med Hypotheses 56, 262-272.
65. Meisel H (2005) Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 12, 1905-1919.
66. Meisel H & Hagemeister H (1984) Zum Einfluss unterschiedlicher technologischer Behandlung von Mitch auf die Verdauungsvorgange im Magen. II. Magenpassage verschiedener Milchinhaltsstoffe. (Influence of different technological treatments of milk on digestion in the stomach. II. Gastric passage of different milk constituents). Milchwissenschaft 39, 262-266.
67. Meloni T, Marinaro A, Mannazzu M, Ogana A, La Vecchia C, Negri E & Colombo C (1997) IDDM and early infant feeding. Sardinian case-control study. Diabetes Care 20, 340-342.
68. 2 breath test study. Eur J Nutr 44, 436-444.
69. Michalski M, Briard V, Michel F, Tasson F & Poulain P (2005a) Size distribution of fat globules in human colostrum, breast milk, and infant formula. J Dairy Sci 88, 1927-1940.
70. Michalski M, Cariou R, Michel F & Garnier C (2002b) Native vs damaged milk fat globules: Membrane properties affect the viscoelasticity of milk gels. J Dairy Sci 85, 2451-2461.
71. Michalski M & Januel C (2006) Does homogenization affect the human health properties of cow's milk? Trends Food Sci Technol 17, 423-437.
72. Michalski M, Leconte N, Briard V, Fauquant J, Maubois J & Goudédranche H (2006b) Microfiltration of raw whole milk to select fractions with different fat globule size distributions: Process optimization and analysis. J Dairy Sci 89, 3778-3790.
73. Michalski M, Michel F & Briard V (2002c) On the size distribution and zeta-potential of homogenized milk fat globules. In Food Emulsions and Dispersions, pp. 49-65 [M Anton, editor]. Kerala, India: Research Signpost.
74. Michalski M, Michel F & Geneste C (2002a) Appearance of submicronic particles in the milk fat globule size distribution upon mechanical treatments. Lait 82, 193-208.
75. Michalski M, Soares A, Lopez C, Leconte N, Briard V & Géloën A (2006a) The supramolecular structure of milk fat influences plasma triacylglycerols and fatty acid profile in the rat. Eur J Nutr 45, 215-224.
76. Morgan F, Leonil J, Molle D & Bouhallab S (1999) Modification of bovine beta-lactoglobulin by glycation in a powdered state or in an aqueous solution: Effect on association behavior and protein conformation. J Agric Food Chem 47, 83-91.
77. Moss M & Freed D (2003) The cow and the coronary: Epidemiology, biochemistry and immunology. Int J Cardiol 87, 203-216.
78. Mulder H & Walstra P (1974) The Milk Fat Globule. Emulsion Science as Applied to Milk Products and Comparable Foods. Farnham Royal, UK: Commonwealth Agricultural Bureaux.
79. Murakami M, Tonouchi H, Takahashi R, Kitazawa H, Kawai Y, Negishi H & Saito T (2004) Structural analysis of a new antihypertensive peptide (beta-lactosin B) isolated from a commercial whey product. J Dairy Sci 87, 1967-1974.
80. Nielsen B, Poulsen O & Hau J (1989) Reagin production in mice: Effect of subcutaneous and oral sensitization with untreated bovine milk and homogenized bovine milk. In Vivo 3, 271-274.
81. Oster K (1972) Evaluation of serum cholesterol reduction and xanthine oxidase inhibition in the treatment of atherosclerosis. In Mycardial Metabolism Vol. 3: Recent Advances in Studies on Cardiac Structure and Metabolism, pp. 73-80 [N Dhalla, editor]. Baltimore, MD: University Park Press.
82. Paajanen L (2005) Effects of cow's milk and its processing on gastrointestinal symptoms and delayed-type immune responses. Doctoral Thesis, Foundation for Nutrition Research, Helsinki, Finland.
83. Paajanen L, Korpela R, Tuure T, Honkanen J, Järvelä I, Ilonen J, Knip M, Vaarala O & Kokkonen J (2005a) Cow milk is not responsible for most gastrointestinal immune-like syndromes - evidence from a population-based study. Am J Clin Nutr 82, 1327-1335.
84. Paajanen L, Tuure T, Poussa T & Korpela R (2003) No difference in symptoms during challenges with homogenized and unhomogenized cow's milk in subjects with subjective hypersensitivity to homogenized milk. J Dairy Res 7, 175-179.
85. PaaJanen L, Tuure T, Vaarala O & Korpela R (2005b) Homogenization of milk has no effect on milk-specific antibodies in healthy adults. Milchwissenschaft 6, 239-241.
86. Padberg S, Schumm-Dräger P, Petzoldt R, Becker F & Federlin K (1999) (The significance of A1 and A2 antibodies against b-casein in type-1 diabetes mellitus) (in German). Dtsch Med Wochenschr 124, 1518-1521.
87. Pafylias I, Cheryan M & Mehaia M (1996) Microfiltration of milk with ceramic membranes. Food Res Int 29, 141-146.
88. Parodi P (1997) Cow's milk fat components as potential anticarcinogenic agents. J Nutr 127, 1055-1060.
89. Paschke A & Besler M (2002) Stability of bovine allergens during food processing. Ann Allergy Asthma Immunol 89, 16-20.
90. Pelto L, Rantakokko H-K, Lilius E-M, Nuutila J & Salminen S (2000) No difference in symptoms and receptor expression in lactose-intolerant and in milk-hypersensitive subjects following intake of homogenized and unhomogenized milk. Int Dairy J 10, 799-803.
91. Pfeil R (1984) Zum Einfluss unterschiedlicher technologischer Behandlung von Milch auf die Verdauungsvorgange im Magen. III. Proteolyse im Magen. (Influence of different technological treatments of milk on digestion in the stomach. III. Proteolysis in the stomach). Milchwissenschaft 39, 267-270.
92. Pfeuffer M & Schrezenmeir J (2000) Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr 84, S155-S159.
93. Poulsen O & Hau J (1987) Homogenization and allergenicity of milk. Some possible implications for the processing of infant formulae. North Eur Food Dairy J 53, 239-242.
94. Poulsen O, Hau J & Kollerup J (1987) Effect of homogenization and pasteurization on the allergenicity of bovine milk analysed by a murine anaphylactic shock model. Clin Allergy 17, 449-458.
95. Poulsen O, Nielsen B, Basse A & Hau J (1990) Comparison of intestinal anaphylactic reactions in sensitized mice challenged with untreated bovine milk and homogenized bovine milk. Allergy 45 (5), 321-326.
96. Riccio P (2004) The proteins of the milk fat globule membrane in the balance. Trends Food Sci Technol 15, 458-461.
97. Rombaut R & Dewettinck K (2006) Properties, analysis and purification of milk polar lipids. Int Dairy J 16, 1362-1373.
98. Saboya L & Maubois J (2000) Current developments of microfiltration technology in the dairy industry. Lait 8, 541-553.
99. Sachdeva S, Jain S, Ram J & Agarwal G (2001) Use of microfiltration to obtain long shelf life milk. Indian J Dairy Sci 54, 297-304.
100. Sanchez C & Frémont S (2003) Conséquences des traitements thermiques et de la formulation sur la structure et l'allergénicité des protéines alimentaires. (Consequences of heat treatment and processing of food on the structure and allergenicity of component proteins). Rev Fr Allergol Immunol Clin 43, 13-20.
101. Sanggaard K, Holst J, Rehfeld J, Sandstrom B, Raben A & Tholstrup T (2004) Different effects of whole milk and a fermented milk with the same fat and lactose content on gastric emptying and postprandial lipaemia, but not on glycaemic response and appetite. Br J Nutr 92, 447-459.
102. Sarti C & Gallagher J (2006) The metabolic syndrome, Prevalence, CHD risk, and treatment. J Diabetes Complications 20, 121-132.
103. Schrezenmeir J & Jagla A (2000) Milk and diabetes. J Am Coll Nutr 19, 176S-190S.
104. Séverin S & Wenshui X (2005) Milk biologically active components as nutraceuticals: A review. Crit Rev Food Sci Nutr 45, 645-656.
105. Sharma S & Dalgleish D (1994) Effect of heat treatments on the incorporation of milk serum proteins into the fat globule membrane of homogenized milk. J Dairy Res 61, 375-384.
106. Sicherer S & Leung D (2005) Advancas in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs and insects. J Allergy Clin Immunol 116, 153-163.
107. Sieber R, Eyer H & Luginbuhl W (1997) L'homogénéisation du lait. Le Laitier Roman 123, 7-9.
108. Silva S & Maltaca F (2005) Caseins as source of bioactive peptides. Int Dairy J 15, 1-15.
109. Sipetic S, Vlajinac H, Kocev N, Bjekic M & Sajic S (2005) Early infant diet and risk of type 1 diabetes mellitus in Belgrade children. Nutrition 21, 474-479.
110. Spitsberg V (2005) Invited review: Bovine milk fat globule membrane as a potential nutraceutical. J Dairy Sci 88, 2289-2294.
111. Strand F (1994) Primary prevention of insulin-dependent diabetes mellitus: Simple approaches using thermal modification of milk. Med Hypotheses 42, 110-114.
112. Tholstrup T (2006) Dairy products and cardiovascular disease. Curr Opin Lipidol 17, 1-10.
113. Tholstrup T, Høy C, Normann Andersen L, Christensen R & Sandström B (2005) Does fat in milk, butter and cheese affect blood lipids and cholesterol differently? J Am Coll Nutr 23, 169-176.
114. Timmen H & Precht D (1984) Zum Einfluss unterschiedlicher technologischer Behandlung von Mitch auf die Verdauungsvorgange im Magen. V. Lipolyse im Magen. (Influence of different technological treatments of milk on digestion in the stomach. V. Lipolysis in the stomach). Milchwissenschaft 39, 276-280.
115. Trujillo A, Capellas M, Salso J, Gervilla R & Guamis B (2002) Applications of high hydrostatic pressures on milk and dairy products: A review. Innov Food Sci Emerg Technol 3, 295-307.
116. Truswell A (2005) The A2 milk case: A critical review. Eur J Clin Nutr 59, 623-631.
117. Truswell A (A006) Reply: The A2 milk case: a critical review. Eur J Clin Nutr 60, 924-925.
118. Vesa T, Korpela R & Korpela R (1997) Milk fat does not affect the symptoms of lactose intolerance. Eur J Clin Nutr 51, 633-636.
119. Vesa T, Marteau P & Korpela R (2000) Lactose intolerance. J Am Coll Nutr 19, 165S-175S.
120. Wal J (2004) Bovine milk allergenicity. Ann Allergy Asthma Immunol 93, 2-11.
121. Walstra P (1974) High-melting triglycerides in the fat globule membrane: an artefact? Neth Milk Dairy J 28, 3-9.
122. Walstra P (1990) On the stability of casein micelles. J Dairy Sci 73, 1965-1979.
123. Walstra P (2003) Physical Chemistry of Foods. New York: Marcel Dekker.
124. Walstra P, Geurts T, Noomen A, Jellama A & van Boekel M (1999) Dairy Technology. Principles of Milk Properties and Processes. New York: Marcel Dekker.
125. Walzem R, Dillard C & German J (2002) Whey components: Millennia of evolution create functionalities for mammalian nutrition: What we know and what we may be overlooking. Crit Rev Food Sci Nutr 42, 353-375.
126. Warensjö E, Jansson J, Berglund L, Boman K, Ahren B, Weinehall L, Lindahl B, Hallmans G & Vessby B (2004) Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. Br J Nutr 91, 635-642.
127. Westphal S, Kastner S, Taneva E, Leodolter A, Dierkes J & Luley C (2004) Postprandial lipid and carbohydrate responses after the ingestion of a casein-enriched mixed meal. Am J Clin Nutr 80, 284-290.
128. Whitney R (1988) Proteins of milk. In Fundamentals of Dairy Chemistry, pp. 81-169 [N Wong, editor]. New York: Van Nostrand Reinhold.
129. Woodford K (2006) A critique of Truswell's A2 milk review. Eur J Clin Nutr 60, 437-439.
130. Zahar M & Smith D (1996) Adsorption of proteins at the lipid-serum interface in milk systems with various lipids. Int Dairy J 6, 697-708.